rdf:type |
|
lifeskim:mentions |
umls-concept:C0001175,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0029921,
umls-concept:C0031327,
umls-concept:C0032659,
umls-concept:C0043476,
umls-concept:C0205419,
umls-concept:C0449435,
umls-concept:C0674428,
umls-concept:C1280500,
umls-concept:C1382176,
umls-concept:C1512456
|
pubmed:issue |
4
|
pubmed:dateCreated |
2008-2-26
|
pubmed:abstractText |
The study sought to investigate the relationship between efavirenz exposure and the CYP2B6 516G-->T(*6) genotype in HIV/AIDS outpatients, using pharmacokinetic modelling and simulation.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0031-6970
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
64
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
357-65
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18057928-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:18057928-Adult,
pubmed-meshheading:18057928-Algorithms,
pubmed-meshheading:18057928-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:18057928-Benzoxazines,
pubmed-meshheading:18057928-Female,
pubmed-meshheading:18057928-Gene Frequency,
pubmed-meshheading:18057928-Genetic Variation,
pubmed-meshheading:18057928-Genotype,
pubmed-meshheading:18057928-HIV Infections,
pubmed-meshheading:18057928-Humans,
pubmed-meshheading:18057928-Male,
pubmed-meshheading:18057928-Models, Statistical,
pubmed-meshheading:18057928-Oxidoreductases, N-Demethylating,
pubmed-meshheading:18057928-Population,
pubmed-meshheading:18057928-Reverse Transcriptase Inhibitors,
pubmed-meshheading:18057928-Sex Factors,
pubmed-meshheading:18057928-Zimbabwe
|
pubmed:year |
2008
|
pubmed:articleTitle |
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.
|
pubmed:affiliation |
Department of DMPK & BAC, African Institute of Biomedical Science and Technology (AiBST), P.O.Box 2294, Harare, Zimbabwe.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|